Accordingly, in the ACH2.0 perspective the susceptibility to AD is defined by two factors, which determine the timing of the T1 crossing by AβPP-derived iAβ: the rate of accumulation of AβPP-derived iAβ and the extent of the T1 threshold. This evidence concerns the gene APP and Alzheimer disease.